Biology of chronic myelogenous leukemia—signaling pathways of initiation and transformation
- 30 June 2004
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 18 (3) , 545-568
- https://doi.org/10.1016/j.hoc.2004.03.008
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2Blood, 2004
- Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activityCell Death & Differentiation, 2003
- Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studiesSeminars in Hematology, 2003
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLThe Journal of Experimental Medicine, 2000
- Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding ProteinThe Journal of Experimental Medicine, 1999
- An intramolecular SH3-domain interaction regulates c-Abl activityNature Genetics, 1998
- Regulation of Bcl-2 gene expression by BCR-ABL is mediated by RasJournal of Molecular Biology, 1997
- Chronic myelogenous leukemia and exposure to ionizing radiation — a retrospective study of 443 patientsAnnals of Hematology, 1995
- The BCR gene encodes a novel serine/threonine kinase activity within a single exonCell, 1991